Company Filing History:
Years Active: 2011-2014
Title: Soumi Gupta: Innovator in HIV Research
Introduction
Soumi Gupta is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of HIV research, particularly in developing methods to determine the susceptibility of HIV-1 to various anti-HIV drugs. With a total of 2 patents, Gupta's work is vital in advancing treatment options for individuals affected by HIV.
Latest Patents
Gupta's latest patents focus on methods and compositions for determining altered susceptibility of HIV-1 to anti-HIV drugs. These inventions relate to detecting mutations in the gene encoding HIV reverse transcriptase, which are associated with altered susceptibility to non-nucleoside reverse transcriptase inhibitors such as efavirenz, nevirapine, and delavirdine, as well as the nucleoside reverse transcriptase inhibitor AZT and integrase strand transfer inhibitors.
Career Highlights
Soumi Gupta is currently associated with Monogram Biosciences, Inc., where he continues to innovate in the field of HIV research. His work has been instrumental in enhancing the understanding of how HIV can develop resistance to treatment, thereby improving patient outcomes.
Collaborations
Gupta collaborates with notable colleagues, including Signe Fransen and Ellen Paxinos, who contribute to the research and development efforts at Monogram Biosciences, Inc.
Conclusion
Soumi Gupta's contributions to HIV research through his patents and collaborations highlight his commitment to improving treatment strategies for HIV-1. His innovative work continues to pave the way for advancements in the field.